We recently discovered a new resource, CardioVisual, for those living with atrial fibrillation. This free app was created by practicing cardiologists to educate their patients and is available for iPad, iPhone, and Android. To learn more about the app, see: CardioVisual, a New App for Those Living with Afib
In this video interview, Karl-Heinz Kuck, MD talked about what the results of the FIRE AND ICE TRIAL comparing cryoballoon and radiofrequency catheter ablations means for patients and doctors. Watch the video at: Video: FIRE AND ICE Trial with Karl-Heinz Kuck, MD
Five top U.S. heart centers and StopAfib.org, a leading atrial fibrillation (afib) patient advocacy group, are partnering in the National Alliance of Integrated AFib Centers in order to improve the treatment of afib patients. Learn more at: Top U.S. Heart Treatment Centers, Patient Group, Form Alliance to Improve Irregular Heartbeat Care
StopAfib.org has added nine new atrial fibrillation experts to its Global Medical Advisory Board, which is made up of some of the world’s foremost electrophysiologists, surgeons, cardiologists, neurologists, epidemiologists, and researchers at the forefront of atrial fibrillation research and treatment. See who was recently named, and check out the full list of members, at: StopAfib.org […]
StopAfib.org participated in a video series for those living with afib. The latest video, The Top Things You Need to Know When Taking an Anticoagulant, was released on September 29 for World Heart Day. To learn more, and watch the video, go to: StopAfib.org Participates in New Video Series About Atrial Fibrillation and Stroke Risk
We’re finally getting a glimpse into what to expect from edoxaban, the 4th new anticoagulant medication. At the European Society of Cardiology in Amsterdam, it was reported that edoxaban was safer–in other words, had less bleeding–than warfarin for those with deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the […]
This confirms what we already knew… As reported today at the European Society of Cardiology in Amsterdam: “Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of […]
The wildly beating heart, fatigue and other debilitating symptoms are well known to the many millions of people impacted by atrial fibrillation. Some of those who have afib may have no outward symptoms, but are still at risk of serious and long-term damage to the heart.
Symptoms or not, rate control is the common treatment of choice, especially from those healthcare providers who are not well versed in afib treatment options. But this treatment sort of suspends afib patients in a “waiting and watching” middle ground, stuck in limbo with a diminished quality of life and an increased risk of stroke.
StopAfib.org would like to applaud and thank Sen. Michael Crapo [R-ID], Sen. Robert Casey [D-PA], Sen. Daniel Inouye [D-HI], Sen. Daniel Akaka [D-HI], Sen. Marco Rubio [R-FL], and Sen. Patrick Toomey [R-PA] for introducing and passing the Atrial Fibrillation Resolution (S. Res. 243), which promotes increased awareness, diagnosis, and treatment of atrial fibrillation. To learn […]
We have just gotten word that the US Senate has passed the Atrial Fibrillation Resolution (S. Res. 243) by unanimous consent. The resolution, introduced by Sen. Crapo and co-introducers Sen. Casey, Sen. Inouye, Sen. Akaka, Sen. Rubio, and Sen. Toomey, promotes increased awareness, diagnosis, and treatment of atrial fibrillation. More information as it is available.